JAK3 and leukemia: Thus, AG-490 suppresses several signaling pathways, including IL-2-mediated signaling, which is upstream of JAK3 and STAT5A and B. Generally, AG-490 can be used to control the abnormal constitutive activation of JAK2 in leukemia cell lines (114).